Literature DB >> 15458389

Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization.

Christophe D Proulx1, May Simaan, Emanuel Escher, Stéphane A Laporte, Gaétan Guillemette, Richard Leduc.   

Abstract

Most G-protein-coupled receptors that undergo agonist-dependent internalization require the presence of specific cytoplasmic-tail residues to initiate interactions with proteins of the endocytic machinery. Here we show that the UT receptor (urotensin II receptor) undergoes internalization, and that specific serine residues of the receptor's cytoplasmic tail participate in this process. We first observed a time-dependent increase in internalization of the UT receptor expressed in COS-7 cells following binding of the agonist urotensin II. This sequestration was significantly reduced in the presence of sucrose, demonstrating that the agonist-activated UT receptor is internalized in part by clathrin-coated pits. Moreover, the sequestered receptor was co-localized in endocytic vesicles with beta-arrestin1 and beta-arrestin2. To assess whether specific regions of the receptor's cytoplasmic tail were involved in internalization, five UT receptor mutants were constructed. In four constructs the receptor's cytoplasmic tail was truncated at various positions (UTDelta367, UTDelta363, UTDelta350 and UTDelta336), and in the other four adjacent serine residues at positions 364-367 were replaced by Ala (Mut4S). Each mutant, except UTDelta367, demonstrated a significantly reduced internalization rate, thereby revealing the importance of specific serine residues within the cytoplasmic tail of the UT receptor for its ability to be internalized efficiently.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15458389      PMCID: PMC1134679          DOI: 10.1042/BJ20040807

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

2.  Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

Review 3.  Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Can J Physiol Pharmacol       Date:  2002-05       Impact factor: 2.273

4.  Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination.

Authors:  Negin P Martin; Robert J Lefkowitz; Sudha K Shenoy
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

5.  Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

Authors:  A Stirrat; M Gallagher; S A Douglas; E H Ohlstein; C Berry; A Kirk; M Richardson; M R MacLean
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

6.  Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes.

Authors:  Michael Tanowitz; Mark Von Zastrow
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

Review 7.  Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

Authors:  Stephen A Douglas
Journal:  Curr Opin Pharmacol       Date:  2003-04       Impact factor: 5.547

Review 8.  Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

Authors:  S A Douglas; E H Ohlstein
Journal:  Trends Cardiovasc Med       Date:  2000-08       Impact factor: 6.677

9.  Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.

Authors:  Patrick Ziltener; Célia Mueller; Bénédicte Haenig; Michael W Scherz; Oliver Nayler
Journal:  J Recept Signal Transduct Res       Date:  2002 Feb-Nov       Impact factor: 2.092

10.  Internalization of the M2 muscarinic acetylcholine receptor proceeds through an atypical pathway in HEK293 cells that is independent of clathrin and caveolae.

Authors:  A G Roseberry; M M Hosey
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

View more
  5 in total

Review 1.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

2.  Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.

Authors:  Brian J Holleran; Marie-Eve Beaulieu; Christophe D Proulx; Pierre Lavigne; Emanuel Escher; Richard Leduc
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 3.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

4.  Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2.

Authors:  Fanfan Zhou; Andy C Lee; Katja Krafczyk; Ling Zhu; Michael Murray
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

5.  Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity.

Authors:  Laurence Desrues; Thomas Lefebvre; Céline Lecointre; Marie-Thérèse Schouft; Jérôme Leprince; Vincent Compère; Fabrice Morin; François Proust; Pierrick Gandolfo; Marie-Christine Tonon; Hélène Castel
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.